Question 1

What are the potential side effects of Tarceva compared to vinorelbine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer clinical trial (NCT01196078). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer clinical trial (NCT01196078). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if my cancer worsens while I am in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer clinical trial (NCT01196078). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific dietary or lifestyle changes I should consider while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer clinical trial (NCT01196078). Contact the study team or your healthcare provider for specific answers.

Question 5

How will the treatment schedule fit into my daily life?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer clinical trial (NCT01196078). Contact the study team or your healthcare provider for specific answers.

Question 6

What support services are available to help me during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer clinical trial (NCT01196078). Contact the study team or your healthcare provider for specific answers.

What this study is about